首页> 美国卫生研究院文献>British Journal of Cancer >A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours

【2h】

A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours

机译：派姆单抗联合超分割放疗治疗转移性实体瘤的I期临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background We conducted a phase I trial evaluating pembrolizumab+hypofractionated radiotherapy (HFRT) for patients with metastatic cancers.

机译：背景我们进行了一项I期试验，评估派姆单抗+超分割放疗（HFRT）对转移性癌症患者的治疗作用。

著录项

期刊名称 British Journal of Cancer
作者
Amit Maity; Rosemarie Mick; Alexander C. Huang; Sangeeth M. George; Michael D. Farwell; John N. Lukens; Abigail T. Berman; Tara C. Mitchell; Josh Bauml; Lynn M. Schuchter; Mark O’Hara; Lilie L. Lin; Angela Demichele; John P. Christodouleas; Naomi B. Haas; Dana M. Patsch; Stephen M. Hahn; Andy J. Minn; E. John Wherry; Robert H. Vonderheide;
展开▼
作者单位

展开▼
年(卷),期 2018(119),10
年度 2018
页码 1200–1207
总页数 8
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Local Control following Combination Hypofractionated Radiotherapy and Pembrolizumab in A Phase II Trial of Recurrent or Metastatic Adenoid Cystic Carcinoma Patients [J] . Bang A., Mahmood U., Chen Y. H., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：局部对照组合后的次级反应放疗和蛋白在反复性或转移性腺样囊性癌患者的II期试验中
2. LOCAL CONTROL FOLLOWING COMBINATION HYPOFRACTIONATED RADIOTHERAPY AND PEMBROLIZUMAB IN A PHASE II TRIAL OF RECURRENT OR METASTATIC ADENOID CYSTIC CARCINOMA PATIENTS [J] . Bang Andrew, Mahmood Umair, Chen Yu-Hui, Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2019,第期

机译：局部对照组合后次谐波放射治疗和彭咯李柳鼠在复发性或转移性腺样囊性癌患者的II期试验中
3. A Phase I Trial of Pembrolizumab with Hypofractionated Radiation Therapy (HFRT) in Patients with Metastatic Cancers [J] . Maity A., Mick R., Huang A. C., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：转移癌症患者患者PEMBROLIZUAB的蛋白蛋白（HFRT）试验
4. Phase I Clinical Trial with Her-2 B-Cell Chimeric and MultiEpitope Based Peptide Vaccines in Patients with Metastatic and/or Recurrent Solid Tumors [C] . Pravin T.P. Kaumaya, Kevin Chu Foy, Joan Garrett American Peptide Symposium . 2009

机译：患者临床试验与患有转移和/或复发性固体瘤的患者的HER-2 B细胞嵌合和多型肽疫苗
5. Use of Palliative Radiotherapy Among Metastatic Non-small-cell Lung Cancer (NSCLC) Patients in Puerto Rico [D] . ?Quinones Avila, Valerie 2020

机译：在波多黎各的转移性非小细胞肺癌（NSCLC）患者中使用姑息放射治疗
6. Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised non-inferiority phase 3 CHHiP trial [O] . Anna Wilkins, Helen Mossop, Isabel Syndikus, -1

机译：中度局限性前列腺癌患者的低分割放疗与常规分割放疗：2年患者报告的随机非劣效性3期CHHiP试验结果
7. A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours [O] . Amit Maity, Rosemarie Mick, Alexander C. Huang, 2018

机译：彭布罗替卢比与转移性固体肿瘤患者的肺泡蛋白磷脂蛋白的阶段试验

A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅